Cargando…
Treating ischaemic stroke with intravenous tPA beyond 4.5 hours under the guidance of a MRI DWI/T2WI mismatch was safe and effective
PURPOSE: Clinical trials have provided evidence that treating patients with acute ischaemic stroke (AIS) beyond 4.5 hours was feasible. Among them using MRI diffusion-weighted imaging/fluid attenuation inversion response (DWI/FLAIR) mismatch to guide intravenous tissue plasminogen activator (tPA) wa...
Autores principales: | Bai, Qing-ke, Zhao, Zhen-guo, Lu, Lian-jun, Shen, Jian, Zhang, Jian-ying, Sui, Hai-jing, Xie, Xiu-hai, Chen, Juan, Yang, Juan, Chen, Cui-rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475081/ https://www.ncbi.nlm.nih.gov/pubmed/31105973 http://dx.doi.org/10.1136/svn-2018-000186 |
Ejemplares similares
-
tPA or not tPA? Lysis therapy in the setting of COVID‐19 and ECMO
por: Cromartie, Anjelica, et al.
Publicado: (2022) -
Effectiveness of intravenous r-tPA versus UK for acute ischaemic stroke: a nationwide prospective Chinese registry study
por: Wang, Xinhong, et al.
Publicado: (2021) -
To tPA or Not to tPA: Two Medical-Legal Misadventures of Diagnosing a Cerebrovascular Accident as a Stroke Mimic
por: Moore, Malia J., et al.
Publicado: (2019) -
l-Palmitoylcarnitine potentiates plasmin and tPA to inhibit thrombosis
por: Yang, Juan, et al.
Publicado: (2023) -
D1 receptor‐mediated endogenous tPA upregulation contributes to blood‐brain barrier injury after acute ischaemic stroke
por: Wang, Yan, et al.
Publicado: (2020)